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Abstract:  
Background: The effects of  electronic cigarettes on the ocular surface has yet to be shown. The purpose of  the study was to 
assess the impact of  e-cigarette use on the anterior corneal surface integrity.
Methods: Forty three males and 21 females with an average of  21years were required to vape 0.05ml of  e-liquid of  8mg nicotine 
concentration. Corneal epithelial thickness (CET) and Non Invasive Keratograph Tear Break up Time (NIKBUT) measure-
ments were obtained prior to and post vaping. The Optovue iVue optical coherence topographer was used to measure central; 
superior; inferior; nasal and temporal CET and NIKBUT was assessed using the Oculus Keratograph 5M.
Results: There was a mean increase for central corneal epithelial thickness of  0.3448 microns. The superior CET increased 
by 0.2414 microns. The inferior CET increased by 0.2931microns. The nasal CET increased by 0.2069 microns. The temporal 
CET increased by 0.2759 microns. The mean change in NIKBUT post-vaping was an increase of  1.40 seconds. All observations 
occurred at p > 0.05.
Conclusion: The acute effect of  e-cigarette use does not impact corneal epithelial thickness and non-invasive keratography tear 
break up time after 10 puffs mild exposure but more research is needed to assess if  this remains the case with more frequent, 
higher exposure.
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Introduction 
Cigarette smoking is harmful to users and can have severe 
effects on the body. According to the World Health Or-
ganisation (WHO), tobacco is a legal drug that kills many 
of  its users.1 In recent times, many individuals have turned 
to electronic cigarettes, which do not contain tobacco and 
is marketed as a safer option on health. Electronic ciga-
rettes, better known as e-cigarettes, are battery-operated 
devices, which deliver nicotine with flavourings and other 
chemicals to users in a vapour instead of  in smoke. Puff-
ing activates the battery-powered heating device, which 
vaporizes the liquid in the cartridge. The resulting aerosol 
or vapour is then inhaled (called "vaping").2 
Electronic cigarettes According to the Food and Drug 
Administration (FDA), e-cigarettes contain nicotine, 
propylene glycol, glycerine, tobacco flavouring and oth-
er contaminants potentially harmful to humans.3 E-cig-
arettes are designed to deliver nicotine in an aerosolized 
manner that simulates an authentic smoking experience 
without the real smoke.3 The nicotine concentration of  
the solutions or cartridges can be purchased in strengths 
ranging from 0 to 24 mg or more, according to user pref-
erence.3 A study by Goniewicz et al.4 found that the tox-
icants levels in e-cigarette vapour was much lower when 
compared to conventional cigarette smoke. A systematic 
review by Hess et al5 on passive exposure to electronic 
cigarette vapour found that this vapour may pose a health 
risk to bystanders. The toxicants in the vapour may have 
an impact on indoor air quality thus questioning second 
hand exposure of  vapour despite its lower concentrations 
than cigarette smoking.5
Since 2005, the electronic cigarette industry has grown 
from one manufacturer in China to an estimated three 
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billion dollars global business with 466 brands and almost 
8,000 different flavours.6 There is concern that vaping 
will serve as a gateway to nicotine addiction and conven-
tional cigarette smoking, predominantly for young people 
as experimentation is rapidly increasing, with e-cigarette 
use in this group doubling from 2008 to 2012 in North 
America, European Union and Republic of  Korea.6
In 2012, the Medicines and Substances Control Act in 
South Africa states electronic nicotine delivery systems 
are scheduled devices and should be purchased at a phar-
macy with a doctor’s prescription.7 Attractive marketing 
of  e-cigarette’s non-toxicity and appealing flavouring op-
tions are turning many cigarette smokers to vaping, espe-
cially adolescents.8
Smoking-related diseases are primarily attributed to the 
toxicants and carcinogens present in the tobacco smoke 
emitted during the combustion process that is absent in 
vaping.9 Moreover, nicotine present in both conventional 
cigarettes and electronic cigarettes, is not classified as car-
cinogenic by the World Health Organisation and has min-
imal contribution in promoting obstructive lung disease 
and artherosclerotic heart disease.9 Thus, the socioeco-
nomic relief  afforded from vaping over cigarette smoking 
will benefit society by the reduction in health care costs, 
the sparing of  millions of  smoking-related deaths world-
wide, and the positive environmental impact by reducing 
the burning of  vegetable matter.
Zhang et al.10 also indicated that nicotine delivery is highly 
dependent on a number of  factors, including vaping tech-
nique, particle evolution, and cloud effects. Trtchounian 
et al.11 determined that aerosol density for e-cigarettes 
remained fairly constant for the first 10 puffs of  a new 
e-cigarette cartridge.11 However, a decrease in aerosol 
density was observed as each cartridge approached its 
terminal life of  300 puffs.11
Exposure to glycol mist, found in e-cigarette cartridges 
and solutions, may lead to dry eye.12 Dry eye has also been 
investigated in cigarette smokers and has been shown to 
have deteriorating effects on the lipid layer of  the pre-cor-
neal tear film.13 
Acute vaping was found to have immediate adverse phys-
iological effects similar to some of  the effects observed 
with smoking systemically but the long-term health ef-
fects of  vaping are not known.14
There is a paucity of  literature on the use of  e-cigarette 
on the ocular surface. However the effects of  cigarette 
smoking has been shown to lower tear film break-up time 
and corneal and conjunctival sensitivity; and delayed cor-
neal epithelial wound healing from keratitis by an average 
of  23.9 days.15,16 Since smoking disrupts the corneal sur-
face, it remains to be shown whether e-cigarettes have 
a similar effect or none. The focus of  this study was to 
determine the effect of  vaping on its outer-most ocular 
surface, the corneal epithelium with the use of  corneal 
pachymetry and a non-invasive tear stability test.
Methods
This is a quasi-experimental one group pretest posttest 
design, that was conducted at the Discipline of  Optom-
etry; Eye Clinic; University of  KwaZulu-Natal (Westville 
campus), RSA. Participants were recruited using a purpo-
sive sampling technique. The inclusion criteria were par-
ticipants within the legal smoking age of  older than 18 
years. Participants with either acute or chronic systemic 
diseases, history or presence of  corneal diseases; ocular 
or systemic medications; recreational drug users; contact 
lens users and persons who had undergone corneal sur-
gery were excluded.
The study determined the effect of  vaping on corneal ep-
ithelial thickness using Optovue iVue optical coherence 
tomographer (OCT) pachymetry and tear film stability 
was assessed using Non-Invasive Keratograph Break-up 
Time (NIKBUT) with the Oculus keratograph 5M. Data 
collection comprised of  both pre-test and post-test mea-
surements.
The Optovue iVue  was used to generate a corneal scan 
producing a pachymetry map showing corneal epithelial 
thickness for 6 mm of  the cornea in microns. This was 
further divided into the central, superior, inferior, nasal 
and temporal zones. The Optovue is validated as a reli-
able tool for epithelial pachymetry.17
The Oculus Keratograph, has 22 placido rings project-
ed onto the cornea, with more than 1,000 measurement 
points per ring, resulting in 22,000 analyzed data points 
per frame. The video recording lasts up to a maximum 
of  25 seconds, or until the patient’s next blink, whichever 
occurs first.18 
The Oculus Keratograph 5M produced a NIKBUT in 
seconds utilising the percentage of  all tear film segments 
which were broken up. The average tear film break up 
time of  all broken segments is then calculated. Tear film 
stability was classified by levels 0, 1 and 2 with the aver-
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age break-up value. Level zero represented a stable tear 
film of  greater than or equal to 14 seconds. Level one 
represented a critical tear film of  greater than 7 seconds 
but less than 14 seconds and level two represented an 
unstable tear film of  less than 7 seconds.
The Oculus Keratograph 5M provided a simple, non-in-
vasive screening test for dry eye with acceptable repeat-
ability and reproducibility and it should be considered as 
an alternative method in the diagnosis and follow up of  
patients with dry eye.19 
NIKBUT was chosen over Tear Thinning Time (TTT) 
and Tear Break Up Time (TBUT) as this test provided 
an electronic in vivo assessment of  the tear film stabili-
ty independent of  fluorescein and examiner influence. It 
also provided a representation of  tear break-up over time, 
including a tear map showing the size and location of  the 
tear-break region, as well as the first break-up time and an 
average break-up time.20 The oculus keratograph, has 22 
placido rings projected onto the cornea, with more than 
1,000 measurement points per ring, resulting in 22,000 
analyzed data points per frame. The video recording lasts 
up to a maximum of  25 seconds, or until the patient’s 
next blink, whichever occurs first.20
A preliminary study consisting of  11 participants was used 
to determine the amount of  e-liquid required to equate 
to 10 puffs which according to Dawkins et al.21 allowed 
for detection in plasma. Each participant was required to 
vape 10 puffs of  e-liquid of  8mg nicotine concentration 
with the e-cigarette being weighed at different intervals 
on the AS.R series, AS 220.R2 analytical balance scale to 
ensure that the required amount of  e-liquid was vaped as 
a measure of  puffs. This was to allow for the standardi-
sation required for each participant to vape 10 puffs. The 
preliminary study revealed that on average participants 
should vape 10 puffs to consume 0.05ml e-liquid.
Participants were screened prior to admission into the 
study to ensure that the inclusion criteria were satisfied. 
As part of  the screening process a thorough case history 
was conducted to rule out systemic pathology and deter-
mine the smoking status of  the participant. Slit lamp bio-
microscopy was performed to rule out corneal pathology.
Pre-test epithelial pachymetry using the Optovue iVue 
and the NIKTBUT using the Oculus Keratograph 5M 
were obtained.  Two pachymetry readings were obtained 
measurements and one reading was of  the average NIK-
BUT measurement being used for analysis. Measurements 
were conducted by the same two examiners to ensure 
standardisation. Each participant was then required to in-
dividually vape 0.05ml of  e-liquid in a smokers designated 
area of  the study site which was 4.67m by 2.25m with the 
air-conditioning turned off. Immediately after vaping the 
epithelial pachymetry and NIKBUT measurements were 
repeated to obtain post-test measurements.
Ethical considerations
Ethical clearance was obtained prior to commencement 
of  the study from the Biomedical Research Ethics Com-
mittee (BREC) at the University of  KwaZulu-Natal 
(RSA).  Each participant was provided with an informa-
tion document to inform them about the details of  the 
study and a consent form to ensure that they were fully 
aware of  their rights should they consent to participate in 
the study. Gatekeeper permission was obtained prior to 
the commencing the study.
Results
Sixty four participants were admitted into the study of  
which 43 were males and 21 were females with an aver-
age age of  21 years. Fifty eight participants had reliable 
pachymetry scans for corneal epithelial thickness mea-
surements whilst fifty seven scans from topographic data 
were accepted for NIKBUT as reliable.
The corneal measurements were an average of  two mea-
surements whilst the first reading measurement for the 
average NIKBUT was analysed using Statistical Package 
for Social Science (SPSS) version 24. The right eyes of  
each participant were used for data analysis thus 58 eyes 
for the corneal epithelial thickness and 57 eyes for the 
NIKBUT measurements were analysed.
Corneal epithelial thickness analysis
Figure 1 shows for central corneal epithelial thickness a 
change from 52.44 microns pre-vaping to 52.76 microns 
post-vaping. Superior corneal epithelial thickness changed 
from 52.38 microns pre-vaping to 52.56 microns post-va-
ping. Inferior corneal epithelial thickness changed from 
52.97 microns pre-vaping to 53.19 microns post-vaping. 
Nasal corneal epithelial thickness changed from 52.63 mi-
crons pre-vaping to 52.81 microns post-vaping. Temporal 
corneal epithelial thickness changed from 51.64microns 
pre-vaping to 51.87 microns post-vaping. All these obser-
vations were statistically insignificant at p-values greater 
than 0.05.
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 Figure 1: Box and whisker plot for mean corneal epithelial thickness before and after vaping 0.05ml of e-   
 liquid. 
  
Table 1 shows the mean change for central corneal epithe-
lial thickness was -0.3448 microns which was statistically 
insignificant with a p-value of  0.105. The mean change 
for superior corneal epithelial thickness was -0.2414 mi-
crons which was statistically insignificant with a p-value 
of  0.230. The mean change for inferior corneal epithelial 
thickness was -0.2931 microns with a statistically insignif-
icant p-value of  0.169. The mean change for nasal corne-
al epithelial thickness was -0.2069 microns with a statisti-
cally insignificant p-value of  0.269. The mean change for 
temporal corneal epithelial thickness was -0.2759 microns 
with a statistically insignificant p-value of  0.117.
Table 1:  
  N Mean change SD P-value 
Central zone 58 -0.3448 ±1.5955 0.105 
Superior zone 58 -0.2414 ±1.5138 0.230 
Inferior zone 58 -0.2931 ±1.6005 0.169 
Nasal zone 58 -0.2069 ±1.4112 0.269 
Temporal zone 58 -0.2759 ±1.3218 0.117 
  
  
NIKBUT analysis
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Figure 2 shows for the sample the mean average NIK-
BUT changed from 12.72 seconds pre-vaping to 14.12 
seconds post-vaping with a statistically insignificant p-val-
ue of  0.089.
Table 2 shows the mean change in average NIKBUT 
post-vaping was -1.40 seconds with a statistically insignif-
icant p-value of  0.089.
41.1% of  the participants had stable NIKBUT readings 
post-vaping, 42.8% had NIKBUT readings in the inter-
mediate range post-vaping and 16.1 % had unstable NIK-
BUT readings post-vaping.
Table 2: Mean change (microns) in average NIKBUT after vaping 0.05ml of e-liquid. 
A negative reading implies an increase in NIKBUT and a positive reading implies decrease. 
 
 
  
  
  
  N Mean change 
(seconds) 
SD P-Value 
PRE TEST – 
POST TEST 
57 -1.40 ±6.11 0.089 
 
 
 Figure 2: Box and whisker plot for Average NIKBUT before and after vaping 0.05ml of e- liquid. 
Discussion
The results revealed that the specific brand of  e-cigarette 
utilised in this study was not associated with major acute 
physiological changes, causing only statistically insignif-
icant mean changes in corneal epithelial thickness in all 
five zones after exposure to 0.05ml of  e-cigarette vapour, 
as seen in Table 1. Furthermore, despite this, compara-
tively the nasal zone appeared to be influenced the least 
and the superior zone the most. This observation is in 
agreement with Reinstein et al22 who observed the thick-
er nasal and inferior epithelial zones in normal eyes and 
even more so the infero-superior zones having a larger 
difference.
 
NIKBUT analysis showed a mean increase of  1.40 sec-
onds post-vaping. These findings were not in agreement 
with Weislander et al.12 who found that exposure to pro-
pylene glycol mist resulted in dry eye. However, the in-
crease in NIKBUT may be attributed to the time frame 
between participants vaping and the measurement being 
recorded. The NIKBUT is a novel technique of  assessing 
the tear film stability. In the current study, the tear stabil-
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ity was measured with NIKBUT whilst in previous stud-
ies, this was measured using tear break up time, which 
may account for these differences. 
 
In contrast, several studies have shown that conventional 
cigarette smoking has adverse effects on the pre-corneal 
tear film, and that there is a strong association between 
smoking and tear film instability.23,24,15  Satici et al.23 re-
ported that smoking can also cause ocular surface epithe-
lial damage because the smoke comes into direct contact 
with the ocular surface.  Based on this premise this study 
explored the effects of  e-cigarettes, and may for the first 
time described the changes to the anterior corneal surface 
induced by exposure to e-cigarette vapour subject to va-
ping technique or other conditions such as temperature.
Cigarette smoking has been reported to be one of  the 
factors in a multitude of  clinical conditions that cause oc-
ular surface epithelial damage, reduced corneal and con-
junctival sensitivity, increased superficial punctuate stain-
ing and a dysfunctional tear film, resulting in dry eye.15 
Also, Jetton et al16 found a delay in corneal wound healing 
in smokers. In this study, we have shown that exposure 
to e-cigarette vapour has statistically insignificant effect 
on the pre-corneal tear film and corneal epithelial thick-
ness for this novel paradigm. Intuitively, smoke should 
be more disruptive than vapour as smoke occurs over an 
open flame and is a collection of  solid, liquid and gas-
eous particles whilst vapour is a less brutal process and 
is gaseous.
 
0.05ml of  e-liquid or on average 10 puffs of  e-cigarette 
vapour may have influenced the findings. This chosen 
number of  puffs may have been inadequate to effect 
changes. Furthermore, Etter et al.25 found that on av-
erage e-cigarette user vaped 175 puffs per day. The re-
sults of  Goniewicz et al.4 may have beecomplemented if  
there was an increase in the number of  puffs. Further 
suggestions that the individual's puffing topography can 
influence the efficacy of  the nicotine delivery from e-cig-
arette may have influenced the outcome of  this study.4 
Therefore future studies should attempt to standardise 
the puffing topography and in addition increase exposure 
to the daily average of  number of  puffs vapers vape to 
obtain a more realistic observation.
 
Nishitsuka et al.26 evaluated risk factors and determinants 
of  corneal thickness in the Japanese population and con-
cluded that among other factors current smoking was as-
sociated with an increase in corneal thickness. The present 
study’s findings showed a statistically insignificant change 
but did show a negligible amount of  corneal thickening 
post vaping for clinical consideration. Furthermore, find-
ings of  insignificant changes may not be influenced by 
diurnal changes as Du et al.27 demonstrated the corneal 
epithelial thickness appears stable during the daytime.
The results demonstrated an increase in corneal epithelial 
thickness questioning the clinical significance of  e-ciga-
rette vaping. The influence of  this on intra-ocular mea-
surements clinically should be accounted for in e-ciga-
rette users.
 
The current findings demonstrated that acute e-cigarette 
exposure does not have adverse effects on the pre-cor-
neal tear film and corneal epithelial thickness. This may 
agree with the notion that e-cigarettes are safer than con-
ventional cigarettes as evidenced in marketing campaigns 
for acute exposure but with caution. Despite the statisti-
cally insignificant changes noted in this study one should 
not ignore its clinical consideration. The minimal influ-
ence on corneal epithelial thickness and stable NIKBUT 
suggests minimal pre-op and post-op effect on refractive 
surgery measurements. Contact lens wearers who vape 
may also not be affected as the corneal epithelium is sta-
ble and the tear film does not suggest drying considering 
the NIKBUT results. The delayed wound healing from 
corneal ulcers or abrasions may not be compounded in 
vapers in contrast to cigarette smokers. The impact on to-
nometry measurements when factoring pachymetry may 
also stable.
 
Considering the results of  the study showed non-signif-
icant changes, the variability of  instrumentation should 
be discussed to account for this. Tian et al19 used the Oc-
ulus 5M keratograph on normal eyes and found 10.35 ± 
4.22s for average NIKBUT, this is in agreement with the 
present study’s pre-test average NIKBUT of  12.72s and 
post-test average NIKBUT of  14.12s accounting for the 
standard deviation. Reinstein et al22 found the central cor-
neal epithelial thickness to be 53.4 ± 4.6 μm in normal 
corneas. The mean pre-test and post-test central corneal 
epithelial thickness was 52.44 μm and 52.76 μm respec-
tively for this study, thereby accounting for the stability of  
data collection tools and the results obtained in this study. 
However, a recommendation of  repeating post-test mea-
surements a second time until pre-test measurements re-
turned would better implicate vaping as the cause of  the 
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change in measurements observed. Considering the lack 
of  changes demonstrated in the study, a control group 
exposed to cigarette smoke, in future research may accen-
tuate the findings in this study.
 
The increase in corneal epithelial thickness in all zones 
post-vaping coupled with increase in NIKBUT post-va-
ping may suggest a clinical change that may be magnified 
if  there was an increase in the sample size and the amount 
e-liquid vaped. Etter et al25 found that on average e-cig-
arette users vaped 175 puffs a day. The 10 puff  vaping 
protocol was utilized as it allowed for little or no nicotine 
as non-smokers who volunteered for the study may not 
be adversely affected, however this was a limitation of  the 
study. Thus, using vapers only and increasing the number 
of  puffs to a representational vaping behavior may alter 
the finding of  the study.
 
Limitations 
A limited sample size, and a lack of  access to exclusive 
vapers proved challenging from the study population and 
site. Including e-cigarette-naive subjects suggests the in-
fluence of  the ‘learning curve’ to duplicate experienced 
e-cigarette users vaping technique and the amount of  
e-liquid may have not been significant enough to influ-
ence changes to the corneal surface. Thus, the research-
ers recommend the use of  a larger sample size with a 
similar methodology including the use of  non-exposed 
subjects under the same measuring conditions to enhance 
the reliability of  the findings. A further recommendation 
of  a pilot study to improve the vaping technique of  nov-
ice subjects, and the measurements of  corneal epithelial 
thickness and NIKBUT be obtained on separate occa-
sions.
Conclusion
The study highlights the effect of  vaping on anterior 
most corneal integrity. The results revealed that there are 
no statistically significant changes on pre-test post-test 
vaping on NIKBUT measurements. It also found that 
e-cigarette vaping had negligible changes on the thickness 
of  the corneal epithelium. This infers that vaping of  ap-
proximately 10 puffs has negligible changes on the epi-
thelial structure and the stability of  pre-corneal tear film.
The statistically insignificant changes in both corneal ep-
ithelial thickness and NIKBUT post-vaping suggests that 
vaping may not have an irritable influence on the anterior 
most aspect of  the cornea. The researchers would like to 
caution that despite the statistically insignificant changes, 
clinical increase was noted which may be amplified with 
puff  number and repeated vaping throughout the day. In 
conclusion, the findings that the corneal epithelium was 
not disrupted acutely post vaping is not an exhaustive 
conclusion.
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